English

PULMONX CORPORATION

EDGAR

LUNG Current report (8-K) · filed 2026-10-27

Annual consolidated revenue for 2025: about USD 90.5M, using the latest reported figures. The previous period, 2024, was about USD 83.79M.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

22.8 million USD

2026 Q2 · USD

Exact inputs and evidence

Revenue: 22756000 USD Source

Operating margin

-39.8%

2026 Q2 · %

Exact inputs and evidence

Operating Income: -9057000 USD Source
Revenue: 22756000 USD Source

Operating cash flow

-5.2 million USD

2026 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: -15300000 USD Source
Operating Cash Flow: -10100000 USD Source

Free cash flow

-5.2 million USD

2026 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: -15300000 USD Source
Operating Cash Flow: -10100000 USD Source
Capital Expenditure: 10000 USD Source
Capital Expenditure: 9000 USD Source

Cash and cash equivalents: 55.8 million USD 2026-06-30 Source
Exact value

55843000 USD
Long-term debt including current maturities: 37.5 million USD 2026-06-30 Source
Exact value

37531000 USD
Shares outstanding: 42.9 million shares 2026-06-30 Source
Exact value

42948269 shares

Reported share-count change

5.41% · 2.2 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

40743806 shares · 2025-06-30· Source
42948269 shares · 2026-06-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

87.4 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Revenue: 21502000 USD · 2025-07-01 – 2025-09-30 Source
Revenue: 90497000 USD · 2025-01-01 – 2025-12-31 Source
Revenue: 67899000 USD · 2025-01-01 – 2025-09-30 Source
Revenue: 20586000 USD · 2026-01-01 – 2026-03-31 Source
Revenue: 22756000 USD · 2026-04-01 – 2026-06-30 Source

Net income

-48.1 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Net income: -13957000 USD · 2025-07-01 – 2025-09-30 Source
Net income: -54003000 USD · 2025-01-01 – 2025-12-31 Source
Net income: -43578000 USD · 2025-01-01 – 2025-09-30 Source
Net income: -13654000 USD · 2026-01-01 – 2026-03-31 Source
Net income: -10080000 USD · 2026-04-01 – 2026-06-30 Source

Capital expenditure

112 thousand USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Capital expenditure: 439000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 350000 USD · 2025-01-01 – 2025-06-30 Source
Capital expenditure: 452000 USD · 2025-01-01 – 2025-12-31 Source
Capital expenditure: 439000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 9000 USD · 2026-01-01 – 2026-03-31 Source
Capital expenditure: 10000 USD · 2026-01-01 – 2026-06-30 Source
Capital expenditure: 9000 USD · 2026-01-01 – 2026-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-10-27.

Financial data available through: 2025-12-31.

Coverage by financial measure

Revenue: 8 of 11 periods available· newest 2025-12-31
Operating income: 8 of 11 periods available· newest 2025-12-31
Net income: 8 of 11 periods available· newest 2025-12-31
Operating cash flow: 8 of 11 periods available· newest 2025-12-31
Capital expenditure: 8 of 11 periods available· newest 2025-12-31
Total assets: 7 of 11 periods available· newest 2025-12-31
Total liabilities: 7 of 11 periods available· newest 2025-12-31
Current assets: 7 of 11 periods available· newest 2025-12-31
Current liabilities: 7 of 11 periods available· newest 2025-12-31
Cash and cash equivalents: 8 of 11 periods available· newest 2025-12-31
Long-term debt including current maturities: 6 of 11 periods available· newest 2025-12-31
Shares outstanding: 7 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+8%

Prior period

USD 83.79 million

2024-01-01 – 2024-12-31
Current period

USD 90.5 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

90497000 − 83789000 = 6708000 USD

83789000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
90497000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · PULMONX CORPORATION · 2025-12-31 PULMONX CORPORATION (edgar:1127537) Year-over-year change in Revenue: 6708000 USD Concept: fundies:Revenue Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T11:36:41Z Snapshot: 8312818b8303fdc580690b90234ee832d042bbd6939ca93ec4bfd7b58bae1104 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1127537?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 90497000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1127537/000112753726000015/lung-20251231.htm#1787648 Filing: 000112753726000015 Input fundies:Revenue: 83789000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1127537/000112753726000015/lung-20251231.htm#1788640 Filing: 000112753726000015
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 2.39 million

Prior period

−USD 56.39 million

2024-01-01 – 2024-12-31
Current period

−USD 54 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-54003000 − -56394000 = 2391000 USD

-56394000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-54003000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · PULMONX CORPORATION · 2025-12-31 PULMONX CORPORATION (edgar:1127537) Year-over-year change in Net income: 2391000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T11:36:41Z Snapshot: 8312818b8303fdc580690b90234ee832d042bbd6939ca93ec4bfd7b58bae1104 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1127537?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -54003000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1127537/000112753726000015/lung-20251231.htm#1128448 Filing: 000112753726000015 Input fundies:NetIncome: -56394000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1127537/000112753726000015/lung-20251231.htm#1129219 Filing: 000112753726000015
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 900,000

Prior period

−USD 31.5 million

2024-01-01 – 2024-12-31
Current period

−USD 32.4 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-32400000 − -31500000 = -900000 USD

-31500000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-32400000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · PULMONX CORPORATION · 2025-12-31 PULMONX CORPORATION (edgar:1127537) Year-over-year change in Operating cash flow: -900000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T11:36:41Z Snapshot: 8312818b8303fdc580690b90234ee832d042bbd6939ca93ec4bfd7b58bae1104 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1127537?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -32400000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1127537/000112753726000015/lung-20251231.htm#1194127 Filing: 000112753726000015 Input fundies:OperatingCashFlow: -31500000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1127537/000112753726000015/lung-20251231.htm#1194311 Filing: 000112753726000015
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-68.8%

Prior period

USD 1.45 million

2024-01-01 – 2024-12-31
Current period

USD 452,000

2025-01-01 – 2025-12-31

Exact inputs and evidence

452000 − 1447000 = -995000 USD

1447000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
452000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · PULMONX CORPORATION · 2025-12-31 PULMONX CORPORATION (edgar:1127537) Year-over-year change in Capital expenditure: -995000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T11:36:41Z Snapshot: 8312818b8303fdc580690b90234ee832d042bbd6939ca93ec4bfd7b58bae1104 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1127537?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 452000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1127537/000112753726000015/lung-20251231.htm#1160205 Filing: 000112753726000015 Input fundies:CapitalExpenditure: 1447000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1127537/000112753726000015/lung-20251231.htm#1160763 Filing: 000112753726000015
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2025 2025-01-01 – 2025-12-31

Revenue USD 90.5 million 100% of revenue
Cost of revenue USD 23.36 million 26% of revenue
Operating expenses USD 120.8 million 133% of revenue
Operating income −USD 53.66 million −59% of revenue
Tax, interest and other Derived USD 340,000 0.4% of revenue
Net income −USD 54 million −60% of revenue

Cash

Operating cash flow −USD 32.4 million −36% of revenue
Capital expenditure USD 452,000 0.5% of revenue
Free cash flow Derived −USD 32.85 million −36% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2018 Operating loss: operating costs were 175% of revenue.
2019 Operating loss: operating costs were 155% of revenue.
2020 Operating loss: operating costs were 199% of revenue.
2021 Operating loss: operating costs were 198% of revenue.
2022 Operating loss: operating costs were 209% of revenue.
2023 Operating loss: operating costs were 190% of revenue.
2024 Operating loss: operating costs were 169% of revenue.
2025 Operating loss: operating costs were 159% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2018 2018-01-01 – 2018-12-31	20004000	35056000 Derived	-15052000	3427000 Derived	-18479000	-18716000 Derived	Source 2018-01-01 – 2018-12-31: 20004000 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: -15052000 USD Inspect Operating Income Open source 2018-01-01 – 2018-12-31: -18479000 USD Inspect Net Income Open source 2018-01-01 – 2018-12-31: -18400000 USD Inspect Operating Cash Flow Open source 2018-01-01 – 2018-12-31: 316000 USD Inspect Capital Expenditure Open source
2019 2019-01-01 – 2019-12-31	32595000	50433000 Derived	-17838000	2865000 Derived	-20703000	-21520000 Derived	Source 2019-01-01 – 2019-12-31: 32595000 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: -17838000 USD Inspect Operating Income Open source 2019-01-01 – 2019-12-31: -20703000 USD Inspect Net Income Open source 2019-01-01 – 2019-12-31: -20800000 USD Inspect Operating Cash Flow Open source 2019-01-01 – 2019-12-31: 720000 USD Inspect Capital Expenditure Open source
2020 2020-01-01 – 2020-12-31	32733000	65065000 Derived	-32332000	-101000 Derived	-32231000	-31511000 Derived	Source 2020-01-01 – 2020-12-31: 32733000 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: -32332000 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -32231000 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: -30600000 USD Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: 911000 USD Inspect Capital Expenditure Open source
2021 2021-01-01 – 2021-12-31	48416000	95720000 Derived	-47304000	1357000 Derived	-48661000	-45071000 Derived	Source 2021-01-01 – 2021-12-31: 48416000 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: -47304000 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: -48661000 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: -41400000 USD Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 3671000 USD Inspect Capital Expenditure Open source
2022 2022-01-01 – 2022-12-31	53662000	112299000 Derived	-58637000	286000 Derived	-58923000	-46418000 Derived	Source 2022-01-01 – 2022-12-31: 53662000 USD Inspect Revenue Open source 2022-01-01 – 2022-12-31: -58637000 USD Inspect Operating Income Open source 2022-01-01 – 2022-12-31: -58923000 USD Inspect Net Income Open source 2022-01-01 – 2022-12-31: -45100000 USD Inspect Operating Cash Flow Open source 2022-01-01 – 2022-12-31: 1318000 USD Inspect Capital Expenditure Open source
2023 2023-01-01 – 2023-12-31	68675000	130610000 Derived	-61935000	-1092000 Derived	-60843000	-38407000 Derived	Source 2023-01-01 – 2023-12-31: 68675000 USD Inspect Revenue Open source 2023-01-01 – 2023-12-31: -61935000 USD Inspect Operating Income Open source 2023-01-01 – 2023-12-31: -60843000 USD Inspect Net Income Open source 2023-01-01 – 2023-12-31: -37600000 USD Inspect Operating Cash Flow Open source 2023-01-01 – 2023-12-31: 807000 USD Inspect Capital Expenditure Open source
2024 2024-01-01 – 2024-12-31	83789000	141493000 Derived	-57704000	-1310000 Derived	-56394000	-32947000 Derived	Source 2024-01-01 – 2024-12-31: 83789000 USD Inspect Revenue Open source 2024-01-01 – 2024-12-31: -57704000 USD Inspect Operating Income Open source 2024-01-01 – 2024-12-31: -56394000 USD Inspect Net Income Open source 2024-01-01 – 2024-12-31: -31500000 USD Inspect Operating Cash Flow Open source 2024-01-01 – 2024-12-31: 1447000 USD Inspect Capital Expenditure Open source
2025 2025-01-01 – 2025-12-31	90497000	144160000 Derived	-53663000	340000 Derived	-54003000	-32852000 Derived	Source 2025-01-01 – 2025-12-31: 90497000 USD Inspect Revenue Open source 2025-01-01 – 2025-12-31: -53663000 USD Inspect Operating Income Open source 2025-01-01 – 2025-12-31: -54003000 USD Inspect Net Income Open source 2025-01-01 – 2025-12-31: -32400000 USD Inspect Operating Cash Flow Open source 2025-01-01 – 2025-12-31: 452000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 90.5M 2025

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20182018-12-31	Revenue	20004000	Revenue: 20004000 Open source
20192019-12-31	Revenue	32595000	Revenue: 32595000 Open source
20202020-12-31	Revenue	32733000	Revenue: 32733000 Open source
20212021-12-31	Revenue	48416000	Revenue: 48416000 Open source
20222022-12-31	Revenue	53662000	Revenue: 53662000 Open source
20232023-12-31	Revenue	68675000	Revenue: 68675000 Open source
20242024-12-31	Revenue	83789000	Revenue: 83789000 Open source
20252025-12-31	Revenue	90497000	Revenue: 90497000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

8% 2025

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20182018-12-31	Year over year	No prior comparable period	Revenue: 20004000 Open source
20192019-12-31	Year over year	62.9%	Revenue: 32595000 Open source Revenue: 20004000 Open source
20202020-12-31	Year over year	0.4%	Revenue: 32733000 Open source Revenue: 32595000 Open source
20212021-12-31	Year over year	47.9%	Revenue: 48416000 Open source Revenue: 32733000 Open source
20222022-12-31	Year over year	10.8%	Revenue: 53662000 Open source Revenue: 48416000 Open source
20232023-12-31	Year over year	28%	Revenue: 68675000 Open source Revenue: 53662000 Open source
20242024-12-31	Year over year	22%	Revenue: 83789000 Open source Revenue: 68675000 Open source
20252025-12-31	Year over year	8%	Revenue: 90497000 Open source Revenue: 83789000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -59.3% 2025

Net margin -59.7% 2025

Free cash flow margin -36.3% 2025

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20182018-12-31	Operating margin	-75.2%	Operating Income: -15052000 Open source Revenue: 20004000 Open source
20192019-12-31	Operating margin	-54.7%	Operating Income: -17838000 Open source Revenue: 32595000 Open source
20202020-12-31	Operating margin	-98.8%	Operating Income: -32332000 Open source Revenue: 32733000 Open source
20212021-12-31	Operating margin	-97.7%	Operating Income: -47304000 Open source Revenue: 48416000 Open source
20222022-12-31	Operating margin	-109.3%	Operating Income: -58637000 Open source Revenue: 53662000 Open source
20232023-12-31	Operating margin	-90.2%	Operating Income: -61935000 Open source Revenue: 68675000 Open source
20242024-12-31	Operating margin	-68.9%	Operating Income: -57704000 Open source Revenue: 83789000 Open source
20252025-12-31	Operating margin	-59.3%	Operating Income: -53663000 Open source Revenue: 90497000 Open source
20182018-12-31	Net margin	-92.4%	Net Income: -18479000 Open source Revenue: 20004000 Open source
20192019-12-31	Net margin	-63.5%	Net Income: -20703000 Open source Revenue: 32595000 Open source
20202020-12-31	Net margin	-98.5%	Net Income: -32231000 Open source Revenue: 32733000 Open source
20212021-12-31	Net margin	-100.5%	Net Income: -48661000 Open source Revenue: 48416000 Open source
20222022-12-31	Net margin	-109.8%	Net Income: -58923000 Open source Revenue: 53662000 Open source
20232023-12-31	Net margin	-88.6%	Net Income: -60843000 Open source Revenue: 68675000 Open source
20242024-12-31	Net margin	-67.3%	Net Income: -56394000 Open source Revenue: 83789000 Open source
20252025-12-31	Net margin	-59.7%	Net Income: -54003000 Open source Revenue: 90497000 Open source
20182018-12-31	Free cash flow margin	-93.6%	Revenue: 20004000 Open source Operating Cash Flow: -18400000 Open source Capital Expenditure: 316000 Open source
20192019-12-31	Free cash flow margin	-66%	Revenue: 32595000 Open source Operating Cash Flow: -20800000 Open source Capital Expenditure: 720000 Open source
20202020-12-31	Free cash flow margin	-96.3%	Revenue: 32733000 Open source Operating Cash Flow: -30600000 Open source Capital Expenditure: 911000 Open source
20212021-12-31	Free cash flow margin	-93.1%	Revenue: 48416000 Open source Operating Cash Flow: -41400000 Open source Capital Expenditure: 3671000 Open source
20222022-12-31	Free cash flow margin	-86.5%	Revenue: 53662000 Open source Operating Cash Flow: -45100000 Open source Capital Expenditure: 1318000 Open source
20232023-12-31	Free cash flow margin	-55.9%	Revenue: 68675000 Open source Operating Cash Flow: -37600000 Open source Capital Expenditure: 807000 Open source
20242024-12-31	Free cash flow margin	-39.3%	Revenue: 83789000 Open source Operating Cash Flow: -31500000 Open source Capital Expenditure: 1447000 Open source
20252025-12-31	Free cash flow margin	-36.3%	Revenue: 90497000 Open source Operating Cash Flow: -32400000 Open source Capital Expenditure: 452000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -32.4M 2025

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20182018-12-31	Operating cash flow	-18400000	Operating Cash Flow: -18400000 Open source
20192019-12-31	Operating cash flow	-20800000	Operating Cash Flow: -20800000 Open source
20202020-12-31	Operating cash flow	-30600000	Operating Cash Flow: -30600000 Open source
20212021-12-31	Operating cash flow	-41400000	Operating Cash Flow: -41400000 Open source
20222022-12-31	Operating cash flow	-45100000	Operating Cash Flow: -45100000 Open source
20232023-12-31	Operating cash flow	-37600000	Operating Cash Flow: -37600000 Open source
20242024-12-31	Operating cash flow	-31500000	Operating Cash Flow: -31500000 Open source
20252025-12-31	Operating cash flow	-32400000	Operating Cash Flow: -32400000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -32.9M 2025

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20182018-12-31	Free cash flow	-18716000	Operating Cash Flow: -18400000 Open source Capital Expenditure: 316000 Open source
20192019-12-31	Free cash flow	-21520000	Operating Cash Flow: -20800000 Open source Capital Expenditure: 720000 Open source
20202020-12-31	Free cash flow	-31511000	Operating Cash Flow: -30600000 Open source Capital Expenditure: 911000 Open source
20212021-12-31	Free cash flow	-45071000	Operating Cash Flow: -41400000 Open source Capital Expenditure: 3671000 Open source
20222022-12-31	Free cash flow	-46418000	Operating Cash Flow: -45100000 Open source Capital Expenditure: 1318000 Open source
20232023-12-31	Free cash flow	-38407000	Operating Cash Flow: -37600000 Open source Capital Expenditure: 807000 Open source
20242024-12-31	Free cash flow	-32947000	Operating Cash Flow: -31500000 Open source Capital Expenditure: 1447000 Open source
20252025-12-31	Free cash flow	-32852000	Operating Cash Flow: -32400000 Open source Capital Expenditure: 452000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

58.1% 2025

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2018-12-31	Liabilities / assets	Not reported	No source recorded
20192019-12-31	Liabilities / assets	66.4%	Total Liabilities: 35572000 Open source Total Assets: 53533000 Open source
20202020-12-31	Liabilities / assets	14.2%	Total Liabilities: 37574000 Open source Total Assets: 263708000 Open source
20212021-12-31	Liabilities / assets	17.8%	Total Liabilities: 41934000 Open source Total Assets: 235173000 Open source
20222022-12-31	Liabilities / assets	20.5%	Total Liabilities: 39669000 Open source Total Assets: 193676000 Open source
20232023-12-31	Liabilities / assets	33.4%	Total Liabilities: 59466000 Open source Total Assets: 177781000 Open source
20242024-12-31	Liabilities / assets	47.3%	Total Liabilities: 77041000 Open source Total Assets: 162850000 Open source
20252025-12-31	Liabilities / assets	58.1%	Total Liabilities: 75175000 Open source Total Assets: 129291000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

5.07× 2025

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
2018-12-31	Current assets / current liabilities	Not reported	No source recorded
20192019-12-31	Current assets / current liabilities	2.9×	Current Assets: 41071000 Open source Current Liabilities: 14161000 Open source
20202020-12-31	Current assets / current liabilities	19.96×	Current Assets: 249989000 Open source Current Liabilities: 12526000 Open source
20212021-12-31	Current assets / current liabilities	11.85×	Current Assets: 208002000 Open source Current Liabilities: 17550000 Open source
20222022-12-31	Current assets / current liabilities	9.14×	Current Assets: 168953000 Open source Current Liabilities: 18492000 Open source
20232023-12-31	Current assets / current liabilities	6.5×	Current Assets: 150422000 Open source Current Liabilities: 23157000 Open source
20242024-12-31	Current assets / current liabilities	5.58×	Current Assets: 136248000 Open source Current Liabilities: 24437000 Open source
20252025-12-31	Current assets / current liabilities	5.07×	Current Assets: 101684000 Open source Current Liabilities: 20058000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2018 2018-01-01 – 2018-12-31	−USD 18.48 million Exact value Exact value: -18479000 USD 2018-01-01 – 2018-12-31: -18479000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PULMONX CORPORATION · 2018-12-31 PULMONX CORPORATION (edgar:1127537) Net Income: -18479000 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T11:36:41Z Snapshot: 8312818b8303fdc580690b90234ee832d042bbd6939ca93ec4bfd7b58bae1104 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1127537/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -18479000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1127537/000112753721000008/lung-20201231.htm#1736883 Filing: 000112753721000008 The citation records this snapshot. The page link may show a newer release later.	−USD 18.4 million Exact value Exact value: -18400000 USD 2018-01-01 – 2018-12-31: -18400000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PULMONX CORPORATION · 2018-12-31 PULMONX CORPORATION (edgar:1127537) Operating Cash Flow: -18400000 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T11:36:41Z Snapshot: 8312818b8303fdc580690b90234ee832d042bbd6939ca93ec4bfd7b58bae1104 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1127537/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -18400000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1127537/000112753721000008/lung-20201231.htm#1959336 Filing: 000112753721000008 The citation records this snapshot. The page link may show a newer release later.	USD 316,000 Exact value Exact value: 316000 USD 2018-01-01 – 2018-12-31: 316000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PULMONX CORPORATION · 2018-12-31 PULMONX CORPORATION (edgar:1127537) Capital Expenditure: 316000 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T11:36:41Z Snapshot: 8312818b8303fdc580690b90234ee832d042bbd6939ca93ec4bfd7b58bae1104 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1127537/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 316000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1127537/000112753721000008/lung-20201231.htm#1819960 Filing: 000112753721000008 The citation records this snapshot. The page link may show a newer release later.	−USD 18.72 million Calculation and evidence -18400000 − 316000 USD Exact free cash flow: -18716000 USD 2018-01-01 – 2018-12-31: -18400000 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 316000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PULMONX CORPORATION · 2018-12-31 PULMONX CORPORATION (edgar:1127537) Free cash flow: -18716000 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T11:36:41Z Snapshot: 8312818b8303fdc580690b90234ee832d042bbd6939ca93ec4bfd7b58bae1104 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1127537?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -18400000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1127537/000112753721000008/lung-20201231.htm#1959336 Filing: 000112753721000008 Input fundies:CapitalExpenditure: 316000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1127537/000112753721000008/lung-20201231.htm#1819960 Filing: 000112753721000008 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	−USD 20.7 million Exact value Exact value: -20703000 USD 2019-01-01 – 2019-12-31: -20703000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PULMONX CORPORATION · 2019-12-31 PULMONX CORPORATION (edgar:1127537) Net Income: -20703000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T11:36:41Z Snapshot: 8312818b8303fdc580690b90234ee832d042bbd6939ca93ec4bfd7b58bae1104 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1127537/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -20703000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1127537/000112753721000008/lung-20201231.htm#1735716 Filing: 000112753721000008 The citation records this snapshot. The page link may show a newer release later.	−USD 20.8 million Exact value Exact value: -20800000 USD 2019-01-01 – 2019-12-31: -20800000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PULMONX CORPORATION · 2019-12-31 PULMONX CORPORATION (edgar:1127537) Operating Cash Flow: -20800000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T11:36:41Z Snapshot: 8312818b8303fdc580690b90234ee832d042bbd6939ca93ec4bfd7b58bae1104 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1127537/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -20800000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1127537/000112753721000008/lung-20201231.htm#1958804 Filing: 000112753721000008 The citation records this snapshot. The page link may show a newer release later.	USD 720,000 Exact value Exact value: 720000 USD 2019-01-01 – 2019-12-31: 720000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PULMONX CORPORATION · 2019-12-31 PULMONX CORPORATION (edgar:1127537) Capital Expenditure: 720000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T11:36:41Z Snapshot: 8312818b8303fdc580690b90234ee832d042bbd6939ca93ec4bfd7b58bae1104 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1127537/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 720000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1127537/000112753721000008/lung-20201231.htm#1819008 Filing: 000112753721000008 The citation records this snapshot. The page link may show a newer release later.	−USD 21.52 million Calculation and evidence -20800000 − 720000 USD Exact free cash flow: -21520000 USD 2019-01-01 – 2019-12-31: -20800000 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 720000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PULMONX CORPORATION · 2019-12-31 PULMONX CORPORATION (edgar:1127537) Free cash flow: -21520000 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T11:36:41Z Snapshot: 8312818b8303fdc580690b90234ee832d042bbd6939ca93ec4bfd7b58bae1104 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1127537?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -20800000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1127537/000112753721000008/lung-20201231.htm#1958804 Filing: 000112753721000008 Input fundies:CapitalExpenditure: 720000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1127537/000112753721000008/lung-20201231.htm#1819008 Filing: 000112753721000008 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	−USD 32.23 million Exact value Exact value: -32231000 USD 2020-01-01 – 2020-12-31: -32231000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PULMONX CORPORATION · 2020-12-31 PULMONX CORPORATION (edgar:1127537) Net Income: -32231000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T11:36:41Z Snapshot: 8312818b8303fdc580690b90234ee832d042bbd6939ca93ec4bfd7b58bae1104 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1127537/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -32231000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1127537/000112753722000013/lung-20211231.htm#1502688 Filing: 000112753722000013 The citation records this snapshot. The page link may show a newer release later.	−USD 30.6 million Exact value Exact value: -30600000 USD 2020-01-01 – 2020-12-31: -30600000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PULMONX CORPORATION · 2020-12-31 PULMONX CORPORATION (edgar:1127537) Operating Cash Flow: -30600000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T11:36:41Z Snapshot: 8312818b8303fdc580690b90234ee832d042bbd6939ca93ec4bfd7b58bae1104 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1127537/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -30600000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1127537/000112753722000013/lung-20211231.htm#1645254 Filing: 000112753722000013 The citation records this snapshot. The page link may show a newer release later.	USD 911,000 Exact value Exact value: 911000 USD 2020-01-01 – 2020-12-31: 911000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PULMONX CORPORATION · 2020-12-31 PULMONX CORPORATION (edgar:1127537) Capital Expenditure: 911000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T11:36:41Z Snapshot: 8312818b8303fdc580690b90234ee832d042bbd6939ca93ec4bfd7b58bae1104 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1127537/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 911000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1127537/000112753722000013/lung-20211231.htm#1556181 Filing: 000112753722000013 The citation records this snapshot. The page link may show a newer release later.	−USD 31.51 million Calculation and evidence -30600000 − 911000 USD Exact free cash flow: -31511000 USD 2020-01-01 – 2020-12-31: -30600000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 911000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PULMONX CORPORATION · 2020-12-31 PULMONX CORPORATION (edgar:1127537) Free cash flow: -31511000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T11:36:41Z Snapshot: 8312818b8303fdc580690b90234ee832d042bbd6939ca93ec4bfd7b58bae1104 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1127537?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -30600000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1127537/000112753722000013/lung-20211231.htm#1645254 Filing: 000112753722000013 Input fundies:CapitalExpenditure: 911000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1127537/000112753722000013/lung-20211231.htm#1556181 Filing: 000112753722000013 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 48.66 million Exact value Exact value: -48661000 USD 2021-01-01 – 2021-12-31: -48661000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PULMONX CORPORATION · 2021-12-31 PULMONX CORPORATION (edgar:1127537) Net Income: -48661000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T11:36:41Z Snapshot: 8312818b8303fdc580690b90234ee832d042bbd6939ca93ec4bfd7b58bae1104 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1127537/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -48661000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1127537/000112753723000011/lung-20221231.htm#1225734 Filing: 000112753723000011 The citation records this snapshot. The page link may show a newer release later.	−USD 41.4 million Exact value Exact value: -41400000 USD 2021-01-01 – 2021-12-31: -41400000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PULMONX CORPORATION · 2021-12-31 PULMONX CORPORATION (edgar:1127537) Operating Cash Flow: -41400000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T11:36:41Z Snapshot: 8312818b8303fdc580690b90234ee832d042bbd6939ca93ec4bfd7b58bae1104 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1127537/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -41400000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1127537/000112753723000011/lung-20221231.htm#1338226 Filing: 000112753723000011 The citation records this snapshot. The page link may show a newer release later.	USD 3.67 million Exact value Exact value: 3671000 USD 2021-01-01 – 2021-12-31: 3671000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PULMONX CORPORATION · 2021-12-31 PULMONX CORPORATION (edgar:1127537) Capital Expenditure: 3671000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T11:36:41Z Snapshot: 8312818b8303fdc580690b90234ee832d042bbd6939ca93ec4bfd7b58bae1104 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1127537/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3671000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1127537/000112753723000011/lung-20221231.htm#1274782 Filing: 000112753723000011 The citation records this snapshot. The page link may show a newer release later.	−USD 45.07 million Calculation and evidence -41400000 − 3671000 USD Exact free cash flow: -45071000 USD 2021-01-01 – 2021-12-31: -41400000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 3671000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PULMONX CORPORATION · 2021-12-31 PULMONX CORPORATION (edgar:1127537) Free cash flow: -45071000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T11:36:41Z Snapshot: 8312818b8303fdc580690b90234ee832d042bbd6939ca93ec4bfd7b58bae1104 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1127537?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -41400000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1127537/000112753723000011/lung-20221231.htm#1338226 Filing: 000112753723000011 Input fundies:CapitalExpenditure: 3671000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1127537/000112753723000011/lung-20221231.htm#1274782 Filing: 000112753723000011 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−USD 58.92 million Exact value Exact value: -58923000 USD 2022-01-01 – 2022-12-31: -58923000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PULMONX CORPORATION · 2022-12-31 PULMONX CORPORATION (edgar:1127537) Net Income: -58923000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T11:36:41Z Snapshot: 8312818b8303fdc580690b90234ee832d042bbd6939ca93ec4bfd7b58bae1104 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1127537/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -58923000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1127537/000112753724000024/lung-20231231.htm#1122058 Filing: 000112753724000024 The citation records this snapshot. The page link may show a newer release later.	−USD 45.1 million Exact value Exact value: -45100000 USD 2022-01-01 – 2022-12-31: -45100000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PULMONX CORPORATION · 2022-12-31 PULMONX CORPORATION (edgar:1127537) Operating Cash Flow: -45100000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T11:36:41Z Snapshot: 8312818b8303fdc580690b90234ee832d042bbd6939ca93ec4bfd7b58bae1104 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1127537/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -45100000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1127537/000112753724000024/lung-20231231.htm#1194333 Filing: 000112753724000024 The citation records this snapshot. The page link may show a newer release later.	USD 1.32 million Exact value Exact value: 1318000 USD 2022-01-01 – 2022-12-31: 1318000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PULMONX CORPORATION · 2022-12-31 PULMONX CORPORATION (edgar:1127537) Capital Expenditure: 1318000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T11:36:41Z Snapshot: 8312818b8303fdc580690b90234ee832d042bbd6939ca93ec4bfd7b58bae1104 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1127537/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1318000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1127537/000112753724000024/lung-20231231.htm#1153880 Filing: 000112753724000024 The citation records this snapshot. The page link may show a newer release later.	−USD 46.42 million Calculation and evidence -45100000 − 1318000 USD Exact free cash flow: -46418000 USD 2022-01-01 – 2022-12-31: -45100000 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 1318000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PULMONX CORPORATION · 2022-12-31 PULMONX CORPORATION (edgar:1127537) Free cash flow: -46418000 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T11:36:41Z Snapshot: 8312818b8303fdc580690b90234ee832d042bbd6939ca93ec4bfd7b58bae1104 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1127537?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -45100000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1127537/000112753724000024/lung-20231231.htm#1194333 Filing: 000112753724000024 Input fundies:CapitalExpenditure: 1318000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1127537/000112753724000024/lung-20231231.htm#1153880 Filing: 000112753724000024 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−USD 60.84 million Exact value Exact value: -60843000 USD 2023-01-01 – 2023-12-31: -60843000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PULMONX CORPORATION · 2023-12-31 PULMONX CORPORATION (edgar:1127537) Net Income: -60843000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T11:36:41Z Snapshot: 8312818b8303fdc580690b90234ee832d042bbd6939ca93ec4bfd7b58bae1104 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1127537/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -60843000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1127537/000112753725000012/lung-20241231.htm#1131390 Filing: 000112753725000012 The citation records this snapshot. The page link may show a newer release later.	−USD 37.6 million Exact value Exact value: -37600000 USD 2023-01-01 – 2023-12-31: -37600000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PULMONX CORPORATION · 2023-12-31 PULMONX CORPORATION (edgar:1127537) Operating Cash Flow: -37600000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T11:36:41Z Snapshot: 8312818b8303fdc580690b90234ee832d042bbd6939ca93ec4bfd7b58bae1104 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1127537/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -37600000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1127537/000112753725000012/lung-20241231.htm#1202338 Filing: 000112753725000012 The citation records this snapshot. The page link may show a newer release later.	USD 807,000 Exact value Exact value: 807000 USD 2023-01-01 – 2023-12-31: 807000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PULMONX CORPORATION · 2023-12-31 PULMONX CORPORATION (edgar:1127537) Capital Expenditure: 807000 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T11:36:41Z Snapshot: 8312818b8303fdc580690b90234ee832d042bbd6939ca93ec4bfd7b58bae1104 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1127537/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 807000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1127537/000112753725000012/lung-20241231.htm#1164683 Filing: 000112753725000012 The citation records this snapshot. The page link may show a newer release later.	−USD 38.41 million Calculation and evidence -37600000 − 807000 USD Exact free cash flow: -38407000 USD 2023-01-01 – 2023-12-31: -37600000 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 807000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PULMONX CORPORATION · 2023-12-31 PULMONX CORPORATION (edgar:1127537) Free cash flow: -38407000 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T11:36:41Z Snapshot: 8312818b8303fdc580690b90234ee832d042bbd6939ca93ec4bfd7b58bae1104 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1127537?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -37600000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1127537/000112753725000012/lung-20241231.htm#1202338 Filing: 000112753725000012 Input fundies:CapitalExpenditure: 807000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1127537/000112753725000012/lung-20241231.htm#1164683 Filing: 000112753725000012 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	−USD 56.39 million Exact value Exact value: -56394000 USD 2024-01-01 – 2024-12-31: -56394000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PULMONX CORPORATION · 2024-12-31 PULMONX CORPORATION (edgar:1127537) Net Income: -56394000 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T11:36:41Z Snapshot: 8312818b8303fdc580690b90234ee832d042bbd6939ca93ec4bfd7b58bae1104 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1127537/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: -56394000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1127537/000112753726000015/lung-20251231.htm#1129219 Filing: 000112753726000015 The citation records this snapshot. The page link may show a newer release later.	−USD 31.5 million Exact value Exact value: -31500000 USD 2024-01-01 – 2024-12-31: -31500000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PULMONX CORPORATION · 2024-12-31 PULMONX CORPORATION (edgar:1127537) Operating Cash Flow: -31500000 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T11:36:41Z Snapshot: 8312818b8303fdc580690b90234ee832d042bbd6939ca93ec4bfd7b58bae1104 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1127537/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -31500000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1127537/000112753726000015/lung-20251231.htm#1194311 Filing: 000112753726000015 The citation records this snapshot. The page link may show a newer release later.	USD 1.45 million Exact value Exact value: 1447000 USD 2024-01-01 – 2024-12-31: 1447000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PULMONX CORPORATION · 2024-12-31 PULMONX CORPORATION (edgar:1127537) Capital Expenditure: 1447000 USD Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T11:36:41Z Snapshot: 8312818b8303fdc580690b90234ee832d042bbd6939ca93ec4bfd7b58bae1104 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1127537/explain?concept=fundies%3ACapitalExpenditure&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1447000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1127537/000112753726000015/lung-20251231.htm#1160763 Filing: 000112753726000015 The citation records this snapshot. The page link may show a newer release later.	−USD 32.95 million Calculation and evidence -31500000 − 1447000 USD Exact free cash flow: -32947000 USD 2024-01-01 – 2024-12-31: -31500000 USD · Inspect Operating Cash Flow · Source 2024-01-01 – 2024-12-31: 1447000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PULMONX CORPORATION · 2024-12-31 PULMONX CORPORATION (edgar:1127537) Free cash flow: -32947000 USD Concept: free-cash-flow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T11:36:41Z Snapshot: 8312818b8303fdc580690b90234ee832d042bbd6939ca93ec4bfd7b58bae1104 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1127537?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -31500000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1127537/000112753726000015/lung-20251231.htm#1194311 Filing: 000112753726000015 Input fundies:CapitalExpenditure: 1447000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1127537/000112753726000015/lung-20251231.htm#1160763 Filing: 000112753726000015 The citation records this snapshot. The page link may show a newer release later.
2025 2025-01-01 – 2025-12-31	−USD 54 million Exact value Exact value: -54003000 USD 2025-01-01 – 2025-12-31: -54003000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PULMONX CORPORATION · 2025-12-31 PULMONX CORPORATION (edgar:1127537) Net Income: -54003000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T11:36:41Z Snapshot: 8312818b8303fdc580690b90234ee832d042bbd6939ca93ec4bfd7b58bae1104 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1127537/explain?concept=fundies%3ANetIncome&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:NetIncome: -54003000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1127537/000112753726000015/lung-20251231.htm#1128448 Filing: 000112753726000015 The citation records this snapshot. The page link may show a newer release later.	−USD 32.4 million Exact value Exact value: -32400000 USD 2025-01-01 – 2025-12-31: -32400000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PULMONX CORPORATION · 2025-12-31 PULMONX CORPORATION (edgar:1127537) Operating Cash Flow: -32400000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T11:36:41Z Snapshot: 8312818b8303fdc580690b90234ee832d042bbd6939ca93ec4bfd7b58bae1104 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1127537/explain?concept=fundies%3AOperatingCashFlow&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -32400000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1127537/000112753726000015/lung-20251231.htm#1194127 Filing: 000112753726000015 The citation records this snapshot. The page link may show a newer release later.	USD 452,000 Exact value Exact value: 452000 USD 2025-01-01 – 2025-12-31: 452000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PULMONX CORPORATION · 2025-12-31 PULMONX CORPORATION (edgar:1127537) Capital Expenditure: 452000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T11:36:41Z Snapshot: 8312818b8303fdc580690b90234ee832d042bbd6939ca93ec4bfd7b58bae1104 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1127537/explain?concept=fundies%3ACapitalExpenditure&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 452000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1127537/000112753726000015/lung-20251231.htm#1160205 Filing: 000112753726000015 The citation records this snapshot. The page link may show a newer release later.	−USD 32.85 million Calculation and evidence -32400000 − 452000 USD Exact free cash flow: -32852000 USD 2025-01-01 – 2025-12-31: -32400000 USD · Inspect Operating Cash Flow · Source 2025-01-01 – 2025-12-31: 452000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PULMONX CORPORATION · 2025-12-31 PULMONX CORPORATION (edgar:1127537) Free cash flow: -32852000 USD Concept: free-cash-flow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T11:36:41Z Snapshot: 8312818b8303fdc580690b90234ee832d042bbd6939ca93ec4bfd7b58bae1104 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1127537?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -32400000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1127537/000112753726000015/lung-20251231.htm#1194127 Filing: 000112753726000015 Input fundies:CapitalExpenditure: 452000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1127537/000112753726000015/lung-20251231.htm#1160205 Filing: 000112753726000015 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

34 filings · 2,296 latest values · 2,296 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001127537, 1127537, LUNG, edgar:1127537

Also known as PULMONX, PULMONX CORPORATION, Pulmonx Corp

PULMONX CORPORATION

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Capital expenditure

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2025 2025-01-01 – 2025-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation